Skip to main content
Spyre Therapeutics, Inc. logo

Spyre Therapeutics, Inc. — Investor Relations & Filings

Ticker · SYRE ISIN · US00773J1034 LEI · 52990017AIJPRH3HQH40 US Manufacturing
Open in API
Filings indexed 740 across all filing types
Latest filing 2023-06-09 Declaration of Voting R…
Country US United States of America
Listing US SYRE

About Spyre Therapeutics, Inc.

https://spyre.com/

Spyre Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing next-generation therapeutics for patients with inflammatory bowel disease (IBD) and other immune-mediated conditions. The company's approach involves engineering novel antibodies with prolonged activity in the body, which allows for less frequent dosing. Its pipeline targets validated biological mechanisms and explores the use of these antibodies as both monotherapies and in rational combination therapies. Spyre aims to provide treatment options for various gastrointestinal and rheumatic diseases that offer the potential for enhanced efficacy and greater convenience.

Recent filings

Filing Released Lang Actions
8-K
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated June 6, 2023, by Aeglea BioTherapeutics, Inc. The key content is the submission of matters to a vote of security holders at the 2023 Annual Meeting of Stockholders. It details the voting results for several proposals including election of directors, ratification of auditors, advisory approval of executive compensation, approval of a reverse stock split, and an amendment to the equity incentive plan. The document is focused on reporting the official results of shareholder votes at the annual meeting. There is no detailed financial data or management discussion, nor is it a proxy solicitation or a report publication announcement. The content matches the definition of "Declaration of Voting Results & Voting Rights Announcements" (DVA). The document length is 4558 characters, which is sufficient to contain detailed voting results rather than just an announcement of a report. Therefore, the correct classification is DVA with high confidence.
2023-06-09 English
DEFA14A
Board/Management Information Classification · 95% confidence The document is a Schedule 14A filing, which is a proxy statement or related materials filed pursuant to Section 14(a) of the Securities Exchange Act of 1934. The text includes details about changes in senior management, specifically the departure of the CEO and General Counsel, appointment of a new President and principal executive officer, and related compensation arrangements. This content aligns with announcements about changes in the company's board of directors or senior management. The document length is 2745 characters, which is relatively short and focused on management changes rather than a full report or financial data. Therefore, the appropriate classification is Board/Management Information (MANG).
2023-05-19 English
8-K
Board/Management Information Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is used for current reports on significant events. The content details the departure of directors and officers, appointment of a new president and CEO, and related compensation arrangements. There is no financial data or report attached, nor is it an earnings release or annual report. The focus is on management changes, specifically the termination of the CEO and General Counsel and appointment of a new President. This matches the definition of Board/Management Information (MANG). The document length is 4094 characters, which is consistent with a typical 8-K filing for management changes. Therefore, the appropriate classification is MANG with high confidence.
2023-05-19 English
10-Q
Interim / Quarterly Report Q1 2023
2023-05-11 English
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events. The key section is Item 2.02, which states that the company issued a press release announcing financial results for the quarter ended March 31, 2023. The document includes the press release as an exhibit but does not contain the full financial statements or detailed financial analysis itself. The length is 3732 characters, which is relatively short and consistent with an announcement rather than a full report. According to the rules, if a document is short and announces or attaches a report (like a press release of earnings), it should be classified as an Earnings Release (ER). The document is not the full quarterly report (IR) but an announcement of financial results via press release. Therefore, the correct classification is Earnings Release (ER).
2023-05-11 English
8-K
Investor Presentation Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events or updates by a company. The text includes sections Item 2.02 (Results of Operations and Financial Condition) and Item 7.01 (Regulation FD Disclosure), which mention a corporate presentation being posted and preliminary financial information. The document explicitly states that the financial statements for the quarter ended March 31, 2023, are not finalized and that the information is preliminary. The corporate presentation is attached as Exhibit 99.1. The document is not a full financial report like an Annual Report (10-K) or Interim Report (IR), nor is it a detailed earnings release (ER). It is primarily an announcement of updated financial condition and a corporate presentation. Given the nature of the content and the inclusion of a corporate presentation, the best fitting category is Investor Presentation (IP). The document length is about 4900 characters, which supports it being a substantive filing rather than a brief announcement. Therefore, the classification is IP with high confidence.
2023-04-25 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.